Showing 1‐28 of 500
Small Molecule API & HPAPI Development Capacity
Small Molecules   |  Video
Small Molecule API & HPAPI Development Capacity
This video presents Lonza's capabilities, facility locations, and timelines to assist biopharma companies in identifying suitable ...
/knowledge-center/smallmolecules/w/small-molecule-api-hpapi-development
Linking Rational Design and Material-Sparing Strategies for Enabled Intermediates and Their Drug Products
Small Molecules   |  Webinar (on-demand)
Linking Rational Design and Material-Sparing Strategies for Enabled Intermediates and Their Drug Products
The rapid development of enabled forms and formulations is crucial for tackling the challenges posed by poorly soluble molecules. ...
/knowledge-center/smallmolecules/w/linking-rational-design
Pioneering Capsule Innovation: Accelerating Oral and Inhalable Drug Delivery
Capsules & Health Ingredients   |  Presentation (on-demand)
Pioneering Capsule Innovation: Accelerating Oral and Inhalable Drug Delivery
Watch Dr. Camille Dumont and Meeta Kratz's presentation at CPHI Worldwide 2024. Explore Lonza’s Innovaform™ new innovation center,...
/knowledge-center/chi/pharma/services/innovaform-drug-delivery-presentation
Transforming drug delivery through advanced capsule innovation
Capsules & Health Ingredients   |  R&D Blog post
Transforming drug delivery through advanced capsule innovation
Capsules represent one of the oldest pharmaceutical dosage forms, with a history dating back to ancient Egypt. Despite being known...
/knowledge-center/Blogs/advanced-capsule-innovation
5 min read
Optimizing Spray-Dried Dispersion Processes Through Risk-Based Development
Small Molecules   |  White paper
Optimizing Spray-Dried Dispersion Processes Through Risk-Based Development
This executive summary explores a risk-based approach to process qualification, demonstrating how small-scale experiments can miti...
/knowledge-center/smallmolecules/es/optimizing-spray-dried-dispersion-processes
10 min read
Excipients for Respiratory Delivery of Biologics
Small Molecules   |  Webinar (on-demand)
Excipients for Respiratory Delivery of Biologics
Local administration of biologic Active Pharmaceutical Ingredients to the lung via inhalation has grown in recent years. Dry and l...
/knowledge-center/smallmolecules/w/excipients-respiratory-delivery-biologics
Responsible Sourcing and Manufacturing: Growing Towards a Sustainable Future with Lonza
Capsules & Health Ingredients   |  Interview
Responsible Sourcing and Manufacturing: Growing Towards a Sustainable Future with Lonza
In this article Christine Lebeault, Head of Applied Sustainability, Lonza Capsules & Health Ingredients, gives her perspective on ...
/knowledge-center/chi/Sustainability/responsible-sourcing-and-manufacturing
Capsugel® in-stock vegan capsule program – EMEA
Capsules & Health Ingredients   |  Brochure
Capsugel® in-stock vegan capsule program – EMEA
Select from a variety of vegan options to satisfy your market needs quickly. Experience the many benefits of choosing from our in-...
/knowledge-center/chi/nutra/capsules/capsugel-instock-vegan-capsule-program
Unlocking Pet Joint Health with Collagen - Webinar
Capsules & Health Ingredients   |  Webinar (on-demand)
Unlocking Pet Joint Health with Collagen - Webinar
Walking, running, playing, jumping. In this webinar, learn how you can support active owners’ companions too with Lonza’s UC-II® u...
/knowledge-center/chi/nutra/ingredients/ucii-pets-webinar
From Technology Selection to Final Drug Product
Small Molecules   |  White paper
From Technology Selection to Final Drug Product
Many new active pharmaceutical ingredients (APIs) suffer from poor gastro-intestinal solubility in their crystalline form. This lo...
/knowledge-center/smallmolecules/es/material-sparing-approaches-for-asd-development
Dry Powder Vaccines to Improve Global Access and Pandemic Response
Small Molecules   |  White paper
Dry Powder Vaccines to Improve Global Access and Pandemic Response
Many vaccines require cold chain storage and distribution, limiting their accessibility in resource-poor regions. Dry powder formu...
/knowledge-center/smallmolecules/es/dry-powder-vaccines
15 min read
Micro-dosing: Navigating the Path from Development to Commercialization with Powder-in-Capsule Technology
Small Molecules   |  White paper
Micro-dosing: Navigating the Path from Development to Commercialization with Powder-in-Capsule Technology
Microdosing, a technique involving the administration of precise, minimal drug doses, can significantly accelerate the drug devel...
/knowledge-center/smallmolecules/es/micro-dosing-powder-in-capsule-technology
15 min read
Support the new era of active lifestyle consumers
Capsules & Health Ingredients   |  e-book
Support the new era of active lifestyle consumers
The joint health market is expanding to include a new wave of younger consumers who understand that mobility is inextricably linke...
/knowledge-center/chi/nutra/ingredients/ucii-collagen-active-lifestyle-ebook
UC-II® for Pets: Science Summary
Capsules & Health Ingredients   |  Infographic
UC-II® for Pets: Science Summary
Lonza’s UC-II® undenatured type II collagen is supported by a comprehensive body of brand specific evidence-based research spannin...
/knowledge-center/chi/nutra/ingredients/ucii-pets-science-summary
UC-II® for Pets Brochure
Capsules & Health Ingredients   |  Brochure
UC-II® for Pets Brochure
Just like their human companions, pets face occasional joint discomfort. And similarly as our pets age, they also experience the s...
/knowledge-center/chi/nutra/ingredients/ucii-pets-brochure
Translating Exosome Candidates into Approved Therapies with engEx® Platform Technologies
Cell & Gene   |  Technical/Service brief
Translating Exosome Candidates into Approved Therapies with engEx® Platform Technologies
Exosomes represent one type of extracellular vesicle (EV) generated by all eukaryotic cells. Exosomes are a new modality with trem...
/knowledge-center/biologics/brief/tli-cgt-translating-exosome-candidates
10 min read
An interview with Lisa Prendergast for Next Generation Gene Therapy Vectors Conference
Cell & Gene   |  Article
An interview with Lisa Prendergast for Next Generation Gene Therapy Vectors Conference
Dr. Lisa Prendergast leads innovation for Lonza's Licensing Business Unit, supporting the growth of expression system platforms wh...
/knowledge-center/biologics/a/tli-cgt-lisa-prendergast-interview-next-generation-gene-therapy
7 min read
Experts in Expression: Recent Advances in CHO Upstream Bioproduction
Biologics   |  e-book
Experts in Expression: Recent Advances in CHO Upstream Bioproduction
Constantly evolving biopharmaceutical pipelines require continuous evolution of CHO-based bioproduction platforms for discovery, d...
/knowledge-center/biologics/e/tli-ebook-experts-in-expression-technology
15 min read
Powering the Development of Tomorrow’s Bispecific Antibodies
Biologics   |  Article
Powering the Development of Tomorrow’s Bispecific Antibodies
bYlok® technology is changing the way bispecific antibodies are designed. Achieving the correct heterodimerization of light and he...
/knowledge-center/biologics/a/tli-hemogenyx
15 min read
Cocoon® CAR-T™: Manufacturing Cell Therapies in the Lonza Cocoon® Platform - 9-day Process
Cell & Gene   |  Technical/Service brief
Cocoon® CAR-T™: Manufacturing Cell Therapies in the Lonza Cocoon® Platform - 9-day Process
Performance data of the 9-day process for functionally-closed and automated manufacture of CD19-CAR-T cells using the Lonza Cocoon...
/knowledge-center/cellgene/brief/Cocoon-application-note-9days
Tech Transfer Strategies and Best Practices to Optimize Your Clinical and Commercial Supply
Biologics   |  Webinar (on-demand)
Tech Transfer Strategies and Best Practices to Optimize Your Clinical and Commercial Supply
Tech Transfers for biological products, whether they occur from a pharma company, another CMO, or a different site within the same...
/knowledge-center/biologics/w/tech-transfer-strategies-and-best-practices-to-optimize-your-clinical-and-commercial-supply
Exploring Technologies for cGMP Success with Encapsulation of Nucleic Acid-based Therapeutics
Biologics   |  White paper
Exploring Technologies for cGMP Success with Encapsulation of Nucleic Acid-based Therapeutics
In this white paper, we discuss the challenges and opportunities associated with nucleic acid encapsulation technologies with a pa...
/knowledge-center/biologics/es/mrn-nucleic-acid-based-therapeutics-encapsulation
10 min read
From Lab to Large-Scale Process Validation: Mastering Regulatory Requirements
Biologics   |  Presentation (slides)
From Lab to Large-Scale Process Validation: Mastering Regulatory Requirements
Start with the end in mind: Meticulous planning of CMC activities is a cornerstone of success to launch complex biological molecul...
/knowledge-center/biologics/pres/process-validation-mastering-regulatory-requirements
15 min read
Mastering Biologics Tech Transfers: Key Success Factors
Biologics   |  White paper
Mastering Biologics Tech Transfers: Key Success Factors
Tech transfers play a vital role in ensuring that medicines reach patients on time. This article looks at the steps involved in te...
/knowledge-center/biologics/es/biologics-tech-transfers-key-success-factors
10 min read
Enabled Form Selection for Oral Drug Products Using a Combination of In-Silico Modeling and In-Vitro Measurements
Small Molecules   |  Webinar (on-demand)
Enabled Form Selection for Oral Drug Products Using a Combination of In-Silico Modeling and In-Vitro Measurements
Many new drug candidates face the hurdle of low aqueous solubility, hindering their absorption and progression to clinical trials....
/knowledge-center/smallmolecules/w/enabled-form-selection-for-oral-drug-products
Lonza’s top tips for developing breakthrough vegan supplements, that deliver
Capsules & Health Ingredients   |  Infographic
Lonza’s top tips for developing breakthrough vegan supplements, that deliver
More consumers are embracing vegan lifestyles, which means that the demand for vegan supplements is soaring. When this is paired w...
/knowledge-center/chi/nutra/capsules/vegan-supplements-hard-empty-capsules
Creating Next-Generation CHO Expression Platforms Through Application of Omics Technologies
Biologics   |  Article
Creating Next-Generation CHO Expression Platforms Through Application of Omics Technologies
Chinese hamster ovary (CHO)-based biomanufacturing platforms have transformed the industrial production of biologics such as monoc...
/knowledge-center/biologics/a/tli-application-of-omics-technologies
10 min read
Leveraging the potential of XS® Pichia Expression System
Biologics   |  R&D Blog post
Leveraging the potential of XS® Pichia Expression System
One of the most important goals of genetic engineering, especially within the biopharmaceutical industry space, is the ability to ...
/knowledge-center/Blogs/xs-pichia-expression-system
4 min read
1 2 3 4 ... 18 >
Meet our experts

Our community is composed of technical experts who have decades of experience in a range of topics and project challenges.

View all experts
Meet our Biologics experts
Meet our Small Molecules experts